Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00534365 · ClinicalTrials.gov registry record · Phase 3
Study Comparing TVT With TVT-SECUR for the Treatment of Stress Urinary Incontinence
A Phase 3 study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 281
- Enrollment target
NCT00534365 is a Phase 3 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 281 participants.
The verdict
NCT00534365, a Phase 3 study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 281 participants
- Enrollment target
Study Summary
The purpoe of this study is to compare the safety and efficacy of the tension-free vaginal tape procedure (TVT) to the TVT-SECUR procedure in the treatment of stress urinary incontinence.
Interventions
- DEVICE tension-free vaginal tape
- DEVICE TVT-SECUR device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 281 participants |
| Start Date | 2007-08 |
| Est. Completion | 2011-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00534365
The ClinicalTrials.gov registry entry for NCT00534365 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 281 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which tension-free vaginal tape is the first listed.
NCT00534365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00534365 about?
NCT00534365 is a clinical study titled "Study Comparing TVT With TVT-SECUR for the Treatment of Stress Urinary Incontinence". The purpoe of this study is to compare the safety and efficacy of the tension-free vaginal tape procedure (TVT) to the TVT-SECUR procedure in the treatment of stress urinary incontinence.
What is the current status of trial NCT00534365?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 281 participants. The study started on 2007-08. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00534365?
The interventions under investigation include: tension-free vaginal tape (DEVICE), TVT-SECUR device (DEVICE).
Who is sponsoring clinical trial NCT00534365?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.